9 3 5215 (Hydrochlorothiazide and Moexipril 25 mg / 15 mg)
Pill imprint 9 3 5215 has been identified as Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg.
Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 25 mg / 15 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 9 3 5215
- 25 mg / 15 mg
- Prescription only
- Drug Class:
- ACE inhibitors with thiazides
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose monohydrate
polyethylene glycol 3350
FD&C Red No. 40
FD&C Yellow No. 5
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|54868-3443||Physicians Total Care Inc (repackager)|
More about hydrochlorothiazide/moexipril
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 1 Review – Add your own review/rating
- Drug class: ACE inhibitors with thiazides
- Hydrochlorothiazide and moexipril
- Moexipril and hydrochlorothiazide (Advanced Reading)
Other brands: Uniretic
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.